Skip to content

4Accepted Sep 2, 3:20 PM ET

OptimizeRx (OPRX) CBO Andrew D'Silva Sells 1,432 Shares

OPRXOptimizeRx Corp

Accepted (ET)

3:20 PM

Sep 2, 2026

Filed

Sep 2, 2026

Documents

1

Size

5.4 KB

Summary

OptimizeRx (OPRX) CBO Andrew D'Silva Sells 1,432 Shares

Updated

What Happened Andrew J. D'Silva, Chief Business Officer of OptimizeRx Corp (OPRX), had 1,432 shares withheld by the company to satisfy tax withholding when restricted stock units vested. The withheld shares are reported as a disposition under Section 16: 1,432 shares at $7.86 per share, for a total value of $11,256. This was a tax-withholding action rather than an open-market sale.

Key Details

  • Transaction date: 2026-09-01; Price per share: $7.86; Total value: $11,256.
  • Transaction code: F (shares withheld to cover tax liability on vesting).
  • Footnote: Shares were withheld by the issuer upon RSU vesting to satisfy the reporting person's tax withholding obligations (treated as a disposition under Section 16).
  • Shares owned after the transaction: not disclosed in the provided excerpt.
  • Filing date: 2026-09-02 (filed the next day); no indication this filing was late.

Context Withholding shares to pay taxes on vested restricted stock units is a routine administrative transaction and is reported as a disposition under SEC rules even though no open-market sale occurred. Such withholding actions do not necessarily reflect the insider's view of the company's prospects.

AI-written summary · check the filing